Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 22;3(8):1054-1068.
doi: 10.1016/j.gastha.2024.08.009. eCollection 2024.

Disease Burden and Spectrum of Symptoms that Impact Quality of Life in Pediatric Patients with Eosinophilic Esophagitis

Affiliations
Review

Disease Burden and Spectrum of Symptoms that Impact Quality of Life in Pediatric Patients with Eosinophilic Esophagitis

Mirna Chehade et al. Gastro Hep Adv. .

Abstract

Eosinophilic esophagitis (EoE) is a progressive type 2 inflammatory disease characterized by symptoms related to esophageal dysfunction and significant esophageal eosinophilic infiltration. It can affect patients from infancy through adulthood. Pediatric EoE has a multidimensional impact on the quality of life of both patients and their families. Nonspecific symptoms mimicking other gastrointestinal conditions, such as food refusal, failure to thrive, and feeding difficulties, may profoundly affect young children's eating skills, growth, and psychosocial status, as well as impact family financial conditions. In adolescence, dysphagia and esophageal food impactions often lead to feeding-related anxiety and influence social lives. Delays in diagnosis, arising from lack of awareness among families and clinicians and compensatory eating behaviors, could increase the risk of fibrostenotic complications, which may ultimately add to the symptom burden. Currently available treatment options include proton pump inhibitors, dietary therapies, swallowed topical steroids, esophageal dilation, and biologic therapy. Despite the efficacy of these approaches, disease burden may be further impacted by their limitations, including poor adherence rates, refractory disease, potential long-term safety concerns, and high costs for care. Thus, there is a need for more timely diagnosis in clinical practice and novel targeted disease-modifying therapies better tailored to treat various phenotypes of EoE, aimed at reducing the physical and psychosocial burdens on patients and their caregivers.

Keywords: Disease Burden; Dupilumab; Eosinophilic Esophagitis; Pediatric; Quality of Life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectrum of EoE symptoms among different age groups. EoE symptoms vary between age groups. In preschoolers, food refusal, along with a tendency to eat only certain foods, irritability, vomiting, and abdominal pain, lead to FTT and lack of weight gain. In school-aged children, food refusal, difficulties in introducing new foods to the diet, preference for liquids and soft diets, and a tendency to be “slow eaters” are common symptoms. The most frequent gastrointestinal symptoms include abdominal pain and vomiting in this age group. Adolescents with symptoms of dysphagia and food impaction also maintain a preference for fluid intake or soft diets, tend to be “slow eaters,” and show fear and anxiety at mealtimes. In adults, dysphagia and food impaction are common symptoms, along with chest pain, GERD symptoms, nonspecific pharyngeal discomfort, and, rarely, spontaneous esophageal perforation.,, GERD, gastroesophageal reflux disease.
Figure 2
Figure 2
Pediatric EoE is associated with clinical, psychosocial, and financial burdens. Pediatric EoE has a multidimensional impact on the QOL of both patients and their caregivers. The chronic, progressive nature of EoE results in significant clinical, psychosocial, and financial burdens.

References

    1. Dellon E.S., Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319–332.e3. - PMC - PubMed
    1. Bredenoord A.J., Patel K., Schoepfer A.M., et al. Disease burden and unmet need in eosinophilic esophagitis. Am J Gastroenterol. 2022;117:1231–1241. - PubMed
    1. Chehade M., Jones S.M., Pesek R.D., et al. Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract. 2018;6:1534–1544.e5. - PMC - PubMed
    1. Spergel J.M., Brown-Whitehorn T.F., Beausoleil J.L., et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48:30–36. - PubMed
    1. Visaggi P., Savarino E., Sciume G., et al. Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Therap Adv Gastroenterol. 2021;14 - PMC - PubMed

LinkOut - more resources